| 摘要 |
Pharmaceutical compositions for the treatment of the syndrome known as hemicrania or migraine, comprising 2-(2',6'-dichlorophenyl-amino)-1,3-diazacyclopentene-(2) or a non-toxic acid addition salt thereof as an active ingredient; and a method of treating hemicrania or migraine in humans with such compositions. |
